Furthermore, increasing lines of evidence indicated their involvement in the oncogenesis of breast cancer and in resistance to endocrine therapy; however, there have been few studies on STAT1 in breast cancer, particularly relating to endocrine treatment resistance. The gene discussed is STAT1; the disease is breast carcinoma.